| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA A CALIFORNIA CORPORATION Patent applications |
| Patent application number | Title | Published |
|---|
| 20120027754 | Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6 - The present invention relates to methods of asthma treatment and prevention using α | 02-02-2012 |
| 20110287007 | Treatment and Prevention of Chronic Asthma Using Antagonists of Integrin AlphavBeta6 - The present invention relates to methods of asthma treatment and prevention using α | 11-24-2011 |
| 20110281750 | Identifying High Risk Clinically Isolated Syndrome Patients - Disclosed herein are methods and kits for identifying clinically isolated syndrome (CIS) patients at high risk of developing multiple sclerosis (MS). | 11-17-2011 |
| 20110256605 | CELLS WITH NON-NATURAL PHYSIOLOGIES DERIVED BY EXPRESSING LIGHT-POWERED PROTON PUMPS IN ONE OR MORE MEMBRANES - Methods and procedures for designing and constructing microbes with the ability to harvest light energy are described. In certain embodiments, these methods and procedures are used to construct a photosynthetic yeast based on proteorhodopsin (PR) expression. Proteorhodopsin is a light powered proton pump used by some ocean bacteria to scavenge light energy. By illuminating single yeast cells expressing PR, controlled amounts of energy can be delivered to these cells. A light-harvesting yeast is a unique bioenergetics research platform for investigating the interplay of biofuel production, cellular ATP levels, and the proton-motive-force (pmf). Also, a strain of yeast with light-boosted biomass to biofuel conversion efficiency possesses direct industrial and commercial utility. | 10-20-2011 |
| 20110224223 | MTOR Modulators and Uses Thereof - The present invention provides methods and compositions for selective modulation of certain protein kinases, and especially mTor complexes. The methods and compositions are particularly useful in inhibiting mTor selectively for therapeutic applications. | 09-15-2011 |
| 20100048414 | NOVEL METHODS FOR PREDICTING AND TREATING TUMORS RESISTANT TO DRUG, IMMUNOTHERAPY, AND RADIATION - The present invention relates to methods for prognosis, diagnosis, and treatment of malignant tumors that were treatment resistant. The present invention provides methods of prognosis and diagnosis of multidrug resistant tumors through detection of the expression levels of nuclear co-repressor 2 (“N-CoR2”), histone deacetylases 3 (“HDAC3”), and their associated gene expression biomarkers. The present invention also provides methods of sensitizing tumors to anti-tumor therapeutics by disrupting HDAC3 activation, abrogating the N-CoR2-HDAC3 interaction, inhibiting the activity of either protein, or by down-regulating the expression of either protein. | 02-25-2010 |
| 20090231739 | MATRIX FORMULATION OF KOHLER INTEGRATING SYSTEM AND COUPLED NON-IMAGING LIGHT CONCENTRATOR - Methods for designing optical systems, including homogenizer element(s), that concentrate light from a distant source, such as the sun, onto a target device, such as a solar cell. | 09-17-2009 |
| 20090186036 | Anti-Alpha V Beta 6 Antibodies - Monoclonal antibodies that specifically bind to M.96. Also included are methods of using these antibodies to treat mammals having or at risk of having O06-mediated diseases, or to diagnose % Qmediated diseases. | 07-23-2009 |
| 20090028853 | TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN ALPHAvBETA6 - The present invention relates to methods of asthma treatment and prevention using α | 01-29-2009 |
| 20080314568 | ANISOTROPIC THERMAL AND ELECTRICAL APPLICATIONS OF COMPOSITES OF CERAMICS AND CARBON NANOTUBES - Ceramic materials are converted to materials with anisotropic thermal properties, electrical properties, or both, by forming the ceramics into composites with carbon nanotubes dispersed therein and uniaxially compressing the composites in a direction in which a lower thermal or electrical conductivity is desired. | 12-25-2008 |
